Retrospective Study of Trabectedin in Soft Tissue Sarcomas
Status:
Completed
Trial end date:
2018-10-02
Target enrollment:
Participant gender:
Summary
This is an independent, observational, retrospective post marketing study on the use of
trabectedin in a clinical setting.
A data collection on the clinical use of the drug will help to improve knowledge and might
contribute to optimize the clinical use of the drug.